umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Gemtuzumab Ozogamicin as Post-Consolidation Therapy does not prevent relapse in children with AML: Results of the NOPHO-AML 2094 Study
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics.
Show others and affiliations
2011 (English)In: 53rd ASH Annual Meeting and Exposition, December 10-13, 2011 : Program: Oral and Poster AbstractsSession: 615. Acute Myeloid Leukemia - Therapy, excluding Transplantation: Poster I Saturday, December 10, 2011, 5:30 PM-7:30 PM Hall GH (San Diego Convention Center), 2011, Vol. 118, no 21, 667-667 p.Conference paper, Published paper (Refereed)
Place, publisher, year, edition, pages
2011. Vol. 118, no 21, 667-667 p.
National Category
Pediatrics
Identifiers
URN: urn:nbn:se:umu:diva-53140ISI: 000299597102129OAI: oai:DiVA.org:umu-53140DiVA: diva2:510031
Conference
53rd ASH Annual Meeting and Exposition, December 10-13, 2011
Available from: 2012-03-14 Created: 2012-03-13 Last updated: 2012-03-14Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Forestier, Erik

Search in DiVA

By author/editor
Forestier, Erik
By organisation
Paediatrics
Pediatrics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf